Boltendahl Business & Strategy

Recent transactions

75% LBO acquisition of

creating a national champion of more than EUR 1bn in total retail sales

Boltendahl Business & Strategy
CCP financial advisor

December 2006

acquired 100% of

Laboratorios F5 PROFAS S.L.

Boltendahl Business & Strategy
originated the transaction and acted as exclusive financial advisor of SUIGEN

January 2007

has acquired a 50 % stake in

SECUVITA
Caring for the future

Boltendahl Business & Strategy
acted as exclusive financial adviser
of the sellers

September 2005

Acquired a 70% stake and led an MBI of

Beal Trading SL

Boltendahl Business & Strategy
initiated the transaction and acted as
exclusive financial adviser
of the sellers

January 2006

^volver

M&A targets - Acquisition demands

Sector	Description/Region
Pharmaceuticals	Search for Spain, yearly sales in excess of than EUR 5m, all major therapeutic areas..
Animal Health	Companies with presence in Europe or major Latin American countries.
Pharmaceuticals Generics	Pharmaceutical companies with presence in Spain and Portugal.
Pharmaceuticals Products	Prescription and OTC products - Spain. Preferably with sales over EUR 1m per year.
Pharmaceuticals & OTC	Pharmaceutical companies with presence in major Latin American countries. Sales range between USD 5m and USD 45m.
Pharmaceutical companies	Open buying mandates for pharmaceutical companies based in Europe and Latin America with enterprise values over USD 10m.
Cosmetics	Open search, Spain, sales range EUR 5m to EUR 20m.
Nutraceuticals	Search for Spanish market, more than EUR 3m sales.
Retail	Retail and consumer goods companies with enterprise values between EUR 30m and EUR 250m. Preferably Europe.

Avenida de Bruselas, 5 - Planta 1º
28108 Alcobendas, Madrid
Tel: + 34 91 662 2591
Fax: + 34 91 662 7075